Literature DB >> 17664490

Health economics in the Journal of Clinical Oncology and an evaluation of the indirect costs and benefits associated with adjuvant trastuzumab.

Gilberto de Lima Lopes, Stefan Gluck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17664490     DOI： 10.1200/JCO.2007.12.3760

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

Review 1.  Trastuzumab: a pharmacoeconomic review of its use in early breast cancer.

Authors:  Kate McKeage; Katherine A Lyseng-Williamson
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

2.  Societal costs and benefits of treatment with trastuzumab in patients with early HER2neu-overexpressing breast cancer in Singapore.

Authors:  Gilberto de Lima Lopes
Journal:  BMC Cancer       Date:  2011-05-18       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.